Search results for Desitination Therapy For Heart Failure

How good is Heart mate- 3. as destination therapy in end stage HF . Can it reach Heart transplantation survival rates ?

The primary treatment for end-stage heart failure is heart transplantation, but due to organ shortage and the poor progress in our pursuit for total artificial hearts, LV assist de...

Engineered Dendritic Cells Prevent Cardiac Remodeling

Heart failure, a devastating condition characterized by the heart’s inability to pump blood efficiently, remains a leading cause of global morbidity and mortality. Despite advances...

Evaluating the Effectiveness and Safety of Digitalis Glycosides in Treating Heart Failure

In a groundbreaking advancement in cardiology, recent findings presented at the European Society of Cardiology Heart Failure 2026 Congress have shed new light on the therapeutic po...

'Food-as-Medicine' Improves Life for Heart Failure Patients

WEDNESDAY, April 15, 2026 — For the 6 million Americans recovering from heart failure, the most difficult time for their health often starts the moment they leave the hospital.Pat...

Precise Spatiotemporal Cardiac Repair and Regeneration

In the rapidly advancing landscape of cardiovascular medicine, the future of treating myocardial infarction is being reshaped by groundbreaking developments in spatiotemporal drug...

TARE the Hazards: Bringing High-Risk Patients to the Transplant Finish Line

Glasgow heart failure patient helped out of hospital by 'game-changer' treatment

Stephen Allan was among patients around the UK given the chance to trial the new medication after he suffered complications to his treatment.

Cytokinetics heart drug scores in closely watched trial

Myqorzo’s success in “non-obstructive” hypertrophic cardiomyopathy separates it from Bristol Myers Squibb’s rival Camzyos and opens up a multibillion-dollar market opportunity.

10-Cent Pill Could Transform Heart Failure Treatment Worldwide

New research indicates that low-dose digoxin may provide significant benefits for heart failure patients. A low dose of digoxin may help people with heart failure avoid hospitaliza...

New guidelines for identifying and treating high-risk IEC-HS patients

Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of hematologic malignancies, offering durable responses for patients with otherwise refractory dis...

Why heart failure care requires spaced repetition for doctors

It is 4:50 p.m. on a Thursday. Your last patient is a 67-year-old with heart failure with reduced ejection fraction. He has been hospitalized twice this year. His medications look...

Why heart failure care requires spaced repetition for doctors

It is 4:50 p.m. on a Thursday. Your last patient is a 67-year-old with heart failure with reduced ejection fraction. He has been hospitalized twice this year. His medications look...

Why we mis-understood DIG-Trial for so long ? How can digoxin reduce acute decompensation, but still doesn’t prevent dea...

Here is a brand new study on Digoxin from AIIMS-India , in 2026 that triggered this post. (Ref 2) The DIG trial published more than 3 decades ago,(1997) was a landmark study, that...

Transitional Care Boosts Heart Failure Outcomes in Elders

In an era where the global population is rapidly aging, heart failure remains a formidable challenge in geriatric medicine. The burden of this chronic condition places immense stra...

After a Stroke, 5 Implantable Defibrillators and a Heart Transplant, I’m Stronger than Ever

As told to Jacquelyne FroeberGrowing up, I got my yearly physical at school just like all my other classmates. It was the same drill every time: The doctor checked your spine for s...

Affinia Therapeutics Receives Approval from Health Canada to Initiate the UPBEAT© Trial, a Phase 1/2 Clinical Trial to I...

An investigational medicine that addresses the genetic root cause of BAG3 DCM, AFTX-201 is being evaluated as a treatment for BAG3 DCM in the UPBEAT trial in the U.S. and Canada AF...

Bolus or drip? What the DOSE trial actually showed about heart failure [PODCAST]

Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! What if one of the most common escalation strategies for acute heart failure doesn’t actually impro...

Treating heart failure patients with i.v. furosemide and HSS reduces inflammatory, remodeling markers

A new research paper was published in Volume 18 of Aging-US on March 26, 2026, titled "Effects of intravenous furosemide plus small-volume hypertonic saline solutions on inflammato...

Proton therapy could improve treatment options for dangerous heart rhythm disorder

Proton-based cardiac radioablation may offer a less invasive treatment for patients with hard-to-treat ventricular tachycardia The post Proton therapy could improve treatment optio...